Shalini R: Not All Blood Thinners Are the Same
Shalini R, Registered Nurse at Saudi German Health, shared a post on LinkedIn:
”Notes:10
Not all ‘blood thinners’ are the same – and understanding the difference is key to safer prescribing and better patient outcomes.
This visual highlights the distinction between anticoagulants and antiplatelet agents, two major classes that reduce clot formation through different mechanisms:
Anticoagulants (e.g., warfarin, apixaban, rivaroxaban, dabigatran)
- Work on the coagulation cascade to slow down clot formation
- Commonly used in conditions like atrial fibrillation, DVT, and PE
- Require careful monitoring (especially warfarin)
- Associated with a higher bleeding risk
Antiplatlet drugs (e.g., aspirin, clopidogrel, ticagrelor, prasugrel)
- Prevent platelets from aggregating and forming clots
- Primarily used in arterial disease (e.g., coronary artery disease, stroke prevention)
- Typically lower bleeding risk compared to anticoagulants
Key takeaway:
Anticoagulants target the clotting cascade, while antiplatelets target platelet function-choosing the right class depends on the underlying pathology.
A simple concept, but one that makes a critical difference in clinical decision-making.”
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 15:58Mel Snyder: Beyond Sickle Cell Disease to the Future of Pediatric Genetics
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology
-
Jul 23, 2026, 13:41Colleen Grady: Why Normal Hemoglobin Does Not Exclude Iron Deficiency
-
Jul 23, 2026, 13:22Jacob Kelly: AHA Review Highlights Coffee’s Cardiovascular Benefits